Diabetes Clinical Trials

Showing 7401-7420 of 7,874 trials

Insulin Glargine Injection Treatment in Place of Thiazolidinedione (TZD), Sulfonylurea, or Metformin in Triple Agent Therapy for Type 2 Diabetes Mellitus (T2DM) Adult Subjects With Unsatisfactory Control

NCT00283049

The purpose of this study is to compare the change in hemoglobin A1c (HbA1c) from baseline to Week 12 between the 3 treatment arms.

Diabetes Mellitus, Type 2

Sanofi390 participantsStarted Feb 2006

Bridgewater, New Jersey, United States

COMPLETED

Study of Postprandial Incretin Response in Women With Gestational Diabetes

NCT01274052

The researchers investigated nineteen pregnant women in third trimester and again postpartum. At the experimental days we performed a mealtest and drew blood for analyses of glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), insulin, C-peptide and glucagon. The researchers aimed to investigate whether women with gestational diabetes mellitus exhibit decreased postprandial GLP-1 responses, and if so, whether this deficiency ceases following delivery when normal glucose tolerance is reestablished.

Gestational Diabetes Mellitus

University Hospital, Gentofte, Copenhagen19 participantsStarted Mar 2007

Glostrup Municipality, Denmark

COMPLETEDPhase 3

Variable Bolus Regimen 1-2-3 for Type 2 Diabetes Mellitus

NCT00135083

The purpose of this study is to show the non-inferiority of insulin glulisine administered with 1 meal versus 2 meals versus 3 daily meals, as measured by the change in hemoglobin A1c (HbA1c), from baseline to study week 24.

Diabetes Mellitus, Type 2

Sanofi347 participantsStarted Aug 2004

Insulin Glargine Injection Treatment in Place of Thiazolidinedione (TZD), Sulfonylurea, or Metformin in Triple Agent Therapy for Type 2 Diabetes Mellitus (T2DM) Adult Subjects With Unsatisfactory Control

Study of Postprandial Incretin Response in Women With Gestational Diabetes

Variable Bolus Regimen 1-2-3 for Type 2 Diabetes Mellitus

Related Searches

Insulin Glulisine in Type 2 Diabetes Mellitus

Insulin Glargine v Rosiglitazone as add-on Therapy in Patients Failing Sulfonylurea and Metformin Combination Therapy

Insulin Glargine in Type 2 Diabetes

Insulin Glulisine Administered Pre-meal Versus Post-meal in Adult Subjects With Type 2 Diabetes Mellitus Receiving Insulin Glargine as Basal Insulin

Thiazolidinedione (TZD) on the Diabetic Retinopathy and Nephropathy

Improving Secretion of Insulin in New Onset Diabetes After Renal Transplantation

Pilot Study Of The Effects Of Resveratrol On Endothelial Function In Subjects With Type 2 Diabetes Mellitus

Culturally Tailored Behavioral Diabetes Care Intervention for Korean Americans

Synbiotics and Low Grade Inflammation in Obese Subjects

Interleukin-1 Receptor Antagonist and Insulin Sensitivity

The TANTALUS® II System for the Treatment of Type 2 Diabetes: A Randomized Study

Insulin Dependent Gestational Diabetes Mellitus: Randomized Trial of Induction of Labour at 38 and 40 Weeks of Gestation

Evaluation of the Rimonabant Impact on the Regression of Asymptomatic Damage Caused by Cardiovascular Risk Factors

Single Ascending Dose Study With Healthy Male Volunteers and Type II Diabetic Patients

Effect of Gynostemma Pentaphyllum Tea in Insulin Sensitivity in Type 2 Diabetic Patients

A Study to Evaluate Safety, Tolerability and P-Glucose After Multiple Ascending Oral Doses of AZD1656 in Type 2 Diabetes

Type 2 Diabetes Mellitus Collaborative Genetic Study on Non-aboriginal Taiwanese